Results 291 to 300 of about 377,160 (316)

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccine

The Lancet
Ernesto T A, Marques, Donald S, Burke
openaire   +2 more sources

Virus safety of plasma derivatives

Transfusion Science, 1990
openaire   +1 more source

Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma

Molecular Therapy - Oncolytics, 2021
Kotaro Sugawara, Minoru Tanaka, Yasuyuki Seto   +2 more
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Terri Lynn Shigle, Nassim Hammoudi   +2 more
exaly  

Safety of Virus-Resistant Transgenic Plants Two Decades After Their Introduction: Lessons from Realistic Field Risk Assessment Studies

Annual Review of Phytopathology, 2007
Marc Fuchs, Dennis Gonsalves
exaly  

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

Lancet, The, 2015
Hannah Kibuuka, Mónica Millard, Mary E Enama   +2 more
exaly  

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

Food and Chemical Toxicology, 1998
Keith A Garleb
exaly  

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity

Vaccine, 2004
Xiaojuan Xu, Zili Li, Qigai He
exaly  

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Open Forum Infectious Diseases, 2015
Marnie Elizaga, Mary Allen, Nicole Frahm   +2 more
exaly  

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Lancet, The, 2018
Katherine V Houser, Kaitlyn M Morabito, Zonghui Hu   +2 more
exaly